Natural Dental AG will be exhibiting at the German Association of Oral Implantology meeting November 30 to December 1st, in Wiesbaden Germany. With more than 8,500 members, the German Association of Oral Implantology (DGI) is the largest association of implantologists in ­Europe. The association promotes a close relationship between practitioners and scientists to foster the exchange of knowledge and expertise to raise the standard of care for patients.

“The DGI is the premier dental implantology organization in Europe,” said Ruedger Rubbert, CEO of NDI AG. “We are pleased to support the organization and have an opportunity to showcase the REPLICATE System at this event.”

Natural Dental Implants AG, headquartered in Berlin, Germany, and a U.S. subsidiary based in Dallas, Texas, was founded in 2006 to develop the intellectual property behind the REPLICATE™ Immediate Tooth Replacement System.  Research and development operations began in 2009.

The REPLICATE™ System 2.0 features the REPLICATE™ Tooth, an anatomically-shaped, 100% customized, titanium-zirconia tooth, and the REPLICATE™ Temporary Protective Crown, a customized cover shield designed to protect the REPLICATE Tooth during the healing process. This new approach to single-tooth replacement offers patients an immediate, minimally invasive alternative to traditional dental implants and three-unit bridges.

The REPLICATE Tooth is an anatomical copy of the patient’s natural tooth that fits into the space occupied by the tooth being removed. It is one piece; a super-hydrophilic titanium root fused to a zirconia preparation with an emerging profile similar to that of a natural tooth. Each REPLICATE Tooth component is designed individually and can be modified to overcome anatomical limitations or to meet specific clinical requirements. This unique approach allows general dentists and specialists to immediately replace single and multi-rooted teeth without drilling or altering the adjacent teeth.

The REPLICATE System is available in the European Union and will be offered in the United States pending FDA approval. Visit to learn more.




Leave a Reply

Your email address will not be published. Required fields are marked *